H
ARVEY Cushing recognized the important role of careful anesthesia in surgery. He instituted the frequent monitoring of blood pressure, pulse, and respiration during anesthesia, a standard in our day, but controversial in his time?
Since then neurosurgeons have been alert to the recognized principles of neuroanesthesia, such as the necessity for smooth induction, proper positioning of the patient, and adequate depth of anesthesia. These principles remain valid regardless of the anesthetic agent selected for maintenance during operation. More recently, anestheticinduced changes of intracranial pressure have been studied in clinical as well as experimental situations? ,5,~ It has been shown that most, if not all, of the halogenated volatile anesthetics, such as halothane, may cause an increase in intracranial pressure. Investigators have felt that this increased intracranial pressure is due to the accompanying vasodilation of cerebral blood vessels.
Enflurane (Ethrane) has recently been introduced into this country and recommended by some for neuroanesthesia. 4 It is a nonflammable inhalation anesthetic agent and a derivative of ether. It does not appear to stimulate excess salivation and will readily obtund pharyngeal and laryngeal reflexes. Some early investigators believed that there were no changes in cerebral blood flow (CBF) during enflurane anesthesia. However, Michenfelder and Cucchiara, 5 and Stullken and Sokoll, 8 have indicated that enflurane anesthesia does result in increased CBF in some cases. Since this has been demonstrated, it seems reasonable that the resulting increase of cerebral blood volume might produce changes of intracranial pressure. In an effort to evaluate this change, we have studied the effect of enflurane upon the intracranial pressure of dogs with normal pressure and with artificially elevated intracranial pressure.
Materials and Methods
Anesthesia was induced with thiamylal sodium for the performance of the surgical procedures. Endotracheal intubation was performed and the dog placed on a Bennett anesthesia respirator* with a high concentra-*Puritan-Bennett anesthesia respirator manufactured by Puritan-Bennett Corp., Oak at 13th Street, Kansas City, Missouri. *MICP = mean intracranial pressure; MABP = mean arterial blood pressure; CPP = cerebral perfusion pressure, p > 0.05. tion of oxygen. A femoral artery and vein were cannulated in one lower limb. The arterial cannula was used for monitoring of arterial pressure and sampling of blood for gas analysis.
A burr hole was made in one side of the skull and a small balloon was placed outside the dura for use in elevating intracranial pressure. The cranial defect was sealed except for the balloon connector. Another burr hole was made in the opposite side of the skull and a miniature transistorized pressure transducert was placed between the dura and skull for pressure measurement. A drill hole was also made on this side of the skull, and a small hollow screw was inserted. The dura was perforated by a monopolar coagulating electrode. The screw was then connected to a Statham P23 Db transducer~ and used as another means of assessing intracranial pressure. We found that the screw reflected pressures similar to those recorded from the expensive miniature transistorized transducer, except at very high intracranial pressures.
All pressures were recorded on an eightchannel recorder. were taken at scheduled times for evaluation of PaCO2, PaO2, and pH. End expiratory CO2 was also monitored. II As the dog appeared to be awakening from the thiamylal anesthesia, further anesthesia was begun using a standard vaporizer anesthesia machine and a Bennett anesthesia respirator to maintain the arterial CO2 pressure in the range of 40 4-5 torr. Enflurane was administered in a concentration of 3% in oxygen and maintained for at least 15 minutes. The enflurane was then stopped, and the dog allowed to equilibrate for approximately 10 minutes.
After this time, inflation of the epidural balloon was begun with a slow rate (0.5 cc/min) infusion pump. The intracranial pressure was raised to levels between 20 and 40 mm Hg and time was allowed for compensation to a steady state before proceeding. Then, enflurane in a concentration of 3% in oxygen was again administered and maintained for 15 minutes while intracranial pressure was continuously recorded. Cerebral perfusion pressure (CPP) was calculated as the difference between mean arterial blood pressure and mean subarachnoid intracranial pressure.
Results
The primary results are summarized in Tables 1 and 2 , with the probability quotients II End tidal CO2 monitoring system Model L5114-5 manufactured by Bourns, Inc., Riverside, California. *MICP = mean intracranial pressure; MABP = mean arterial blood pressure; CPP = cerebral perfusion pressure, p < 0.01. calculated. Mean intracranial pressure, mean arterial blood pressure, and CPP were recorded in 10 dogs at control level and at maximal pressure change (peak or maximal drop) during enflurane administration ( Table  1 ). The mean intracranial pressure was then recorded in eight dogs with the epidural balloon inflation, after a relatively steady state was obtained (control). Enflurane was then introduced and maximal change in pressures (peak or maximal drop) was tabulated ( Table 2 ).
An additional observation of note was seen in two animals. In these dogs, the pressure was raised to 30 to 40 mm Hg, and after the period for stabilization, enflurane was administered. Within minutes the pupil ipsilateral to the epidural balloon became dilated, suggesting cerebral herniation related to the administration of the anesthetic agent.
Discussion
It is apparent that in those animals with normal intracranial pressure, although there was a tendency toward increases of intracranial pressure with the use of enflurane, these changes were not significant in terms of the probability quotient. However, in the group of animals with intracranial pressure already increased, highly significant changes of pressure were obtained with the introduction of enflurane. It should be pointed out further that monitoring of the usual parameters of anesthesia such as blood pressure and pulse rate, gave no indication of these large increases of intracranial pressure.
The drop in CPP below 40 mm Hg has been associated by Zwetnow 7 as being indicative of impending cerebral ischemia. He showed that a 15-minute reduction of CPP to less than 40 mm Hg usually produced marked increases in the tissue lactate and pyruvate concentrations and marked decreases in adenosine triphosphate (ATP) concentrations.
The mechanism of increased intracranial pressure with enflurane anesthesia has not been proven beyond doubt, but we would support the hypothesis that direct vasodilation occurs by action of the anesthetic agent. This is not due to an increase in the arterial partial pressure of carbon dioxide, as this was controlled at normocapneic levels. The vasodilati0n effect of enflurane would result in an increase of cerebral blood volume. If the intracranial pressure is already increased, the compensatory mechanisms (that is, a change of brain mass or exit of cerebral spinal fluid with increased pressure) are already stressed or depleted. The small addition to the intracranial content that the increased cerebral blood volume produces, in some instances results in extreme and dangerous rises of intracranial pressure. The finding of a dilated pupil in two animals after the addition of enflurane was serendipitous, but tends to confirm the hypothesis of increased intracranial volume with use of enflurane. In borderline pressure-volume instances cerebral herniation may occur.
In recent years there has been a tendency to dismiss as unimportant the changes produced in intracranial pressure by general anesthetic drugs. These experiments in animals would Enflurane anesthesia and intraeranial pressure suggest, however, that rather severe changes of pressure are possible with a resulting cerebral ischemia that could very logically lead to catastrophic results, not from the operative procedure itself but from the anesthetic used for the procedure.
In enflurane anesthesia an added danger exists, and that is the possibility of seizurelike activity. Both increased muscle activity and seizure-like pattern on electroencephalography have been associated with deep enflurane anesthesia. This is particularly apt to occur if hypocapnia is present. This added problem is now well documented, and the drug insert accompanying the commercial compound provides a warning to this effect. 1 It is our opinion that this anesthetic agent is not safe or satisfactory for neuroanesthesia when increased intracranial pressure is present. Since a barbiturate-nitrous oxidenarcotic-relaxant technique does not increase intracranial pressure) if the level of anesthesia is adequate, it would appear to be a much better anesthetic choice for those patients already at risk with increased intracranial pressure.
